What to Expect During an Autism Stem Cell Therapy Consultation in Istanbul: A Complete Parent Guide

Many parents contact clinics expecting to be told that their child is a candidate and that treatment can be scheduled. While that eagerness is understandable — especially after years of therapies with limited progress — a responsible regenerative medicine clinic does not operate that way. The consultation exists to protect the child and the family, not to accelerate a booking.

A thorough consultation achieves several things. It determines whether the child's diagnosis, age, health status, and medical history make them a suitable candidate. It identifies potential contraindications or factors that might affect safety or outcomes. It gives the medical team enough information to design a protocol that is specific to the child rather than standardized. And it gives parents the honest, detailed answers they need to make an informed decision.

At TurkeyStemcell, we have declined to treat children when the medical review indicated that the timing was not right, that additional diagnostics were needed first, or that the family's expectations did not align with what the therapy could realistically support. That kind of honesty is what distinguishes a medical consultation from a sales conversation.

The process begins when a family reaches out through the consultation request form, WhatsApp, or email. At this stage, the team collects basic information: the child's name, age, diagnosis, country of residence, a brief summary of their developmental history, and the family's primary goals or concerns.

This initial exchange is not a medical evaluation — it is a triage step. It allows the clinical team to understand the family's situation at a high level and determine whether a deeper review is warranted. Families are never pressured at this stage. The goal is simply to open a clear line of communication.

For many international families, this initial contact also addresses practical questions: Is the consultation free? Can it be done remotely? What language will the consultation be in? How long does the entire process take? These logistics matter, especially when families are considering international travel with a child who has specific sensory or behavioral needs.

Once the initial inquiry is complete, parents are asked to share their child's medical records. This typically includes the formal autism diagnosis (with ICD-10 codes such as F84.0, F84.5, or F84.9 where available), any genetic testing or metabolic screening results, developmental assessments, speech and occupational therapy reports, behavioral evaluations, and documentation of any previous medical interventions.

The clinical team reviews these records carefully — not to check a box, but to build a detailed understanding of the child's biological and developmental profile. This review process may take several days, depending on the complexity of the case and the volume of records provided.

Parents should also provide information about current medications, supplements, dietary interventions (such as gluten-free or casein-free diets), known allergies, gastrointestinal history (which is particularly relevant in autism, given the well-documented gut-brain axis connection), sleep patterns, and seizure history if applicable. The more complete the picture, the more precise and safe the treatment planning will be.

This record review is where the medical team begins to assess inflammatory markers, immune patterns, and neurological indicators that inform whether mesenchymal stem cell therapy is a reasonable consideration for the child.

Based on the medical record review, the clinical team conducts a candidacy evaluation. This is the step where the team determines whether the child is a suitable candidate for stem cell therapy — and, equally importantly, identifies any reasons why treatment should not proceed or should be delayed.

Candidacy evaluation considers several factors: the child's age and developmental stage, the severity and pattern of autism spectrum features, the presence or absence of significant comorbidities (such as uncontrolled seizures, active infections, or severe metabolic conditions), previous response to therapies, current immune and inflammatory status, and the family's goals and expectations.

Not every child is a candidate. Some children may need additional diagnostic workup before a decision can be made. Others may be better served by waiting until a particular developmental window or until a comorbid condition is stabilized. The medical team communicates these findings clearly and without sales pressure.

For families who have already explored the autism FAQ and condition-specific content on our site, the candidacy discussion often builds on concepts they have already encountered — such as neuroinflammation, microglial activation, immune modulation, and the role of the gut-brain axis in autism spectrum biology.

For children who are deemed suitable candidates, the next phase of the consultation involves a detailed treatment protocol discussion. This is where the medical team explains exactly what the proposed treatment involves, why specific modalities are recommended, and what the family should realistically expect.

The protocol discussion typically covers the type of stem cells to be used (at TurkeyStemcell, we use Wharton's Jelly-derived mesenchymal stem cells from GMP-certified laboratories), the delivery routes (which may include intravenous, intrathecal, or intranasal administration depending on the child's profile), the number of cells, the inclusion of supportive therapies such as exosome therapy, and the expected timeline for the treatment day itself.

Parents are encouraged to ask questions throughout this discussion. Common questions include: How long does the procedure take? Will my child need sedation? What are the potential side effects? How soon might we see changes? What kind of follow-up is recommended? The medical team answers these directly, with specific reference to the child's case rather than generic responses.

This transparency is essential. Parents who understand exactly what is being proposed — and why — are better equipped to make a confident, informed decision.

One of the most important functions of the consultation is expectation management. Stem cell therapy for autism is not a cure. It is a regenerative support strategy designed to modulate neuroinflammation, support immune balance, and create a more favorable biological environment for neurological development and function.

Some families arrive with very specific hopes: that their child will begin speaking, that behavioral challenges will disappear, that the therapy will produce dramatic and immediate changes. While improvements in communication, behavior, focus, sleep, and gastrointestinal function have been reported by many families, the degree of response varies significantly from child to child.

The medical team discusses this openly during the consultation. They explain what types of changes families have observed, the typical timeline for noticing improvements (often weeks to months rather than days), the importance of continued therapy and support after treatment, and the possibility that some children may respond more than others.

This honesty is not pessimism — it is medical responsibility. Families deserve to make decisions based on realistic information, not inflated promises.

For international families, the consultation also addresses the practical side of treatment planning. This includes recommended travel dates, expected length of stay in Istanbul (typically 4–7 days depending on the protocol), accommodation options near the clinic, airport transfer arrangements, and any special considerations for traveling with a child on the autism spectrum.

Families with children who have significant sensory sensitivities, dietary requirements, or behavioral challenges are supported with specific guidance. The clinic team can advise on quiet hotel environments, familiar food options, scheduling treatments at optimal times for the child, and minimizing sensory overload during the trip.

Istanbul itself is well-suited for medical travel families. It has major international airports with direct flights from most regions, a wide range of accommodation options from luxury hotels to serviced apartments, and a culture of hospitality that extends into the medical environment. Many families combine the treatment stay with a brief period of rest and recovery in a comfortable setting.

The patient journey page provides additional detail on what the travel and treatment experience looks like from arrival to departure.

Cost is a significant factor for most families, and the consultation addresses it directly. Parents receive a clear breakdown of what the proposed protocol costs, what is included (consultations, treatment, laboratory processing, supportive therapies, follow-up), and what is not included (travel, accommodation, additional diagnostics if needed).

There are no hidden fees. The quote provided during the consultation reflects the full treatment cost. Families are also informed about payment timing, accepted payment methods, and whether any portion of the cost may be recoverable through private insurance or health savings accounts in their home country.

Because regenerative medicine for autism is a significant financial commitment, the clinic encourages families to take whatever time they need to review the information, discuss it privately, and reach a decision without pressure. The consultation creates no obligation to proceed.

After the consultation, families receive a written summary of the medical team's findings and recommendations. This includes the candidacy assessment, the proposed protocol, the estimated cost, and any additional steps that may be recommended before treatment (such as updated blood work or specific tests).

Families who decide to proceed are guided through scheduling, travel planning, and pre-treatment preparation. Families who want more time are encouraged to stay in contact and ask follow-up questions as they arise. There is no expiration on the consultation — the information and recommendation remain valid, and the medical team remains available.

For families who are not yet ready for a full consultation but want to learn more, our autism parent resource page and comprehensive autism FAQ provide detailed information about the science, the approach, and the experience of other families who have made this journey.

Families choose our clinic for several reasons that go beyond the treatment itself. The consultation process is thorough, transparent, and medically rigorous. The clinical team has specific experience with autism spectrum conditions and understands the biological complexity — including neuroinflammation, microglial activation, Th1/Th2 immune imbalance, and gut-brain axis involvement — that makes each child's case unique.

The clinic environment in Istanbul is designed to accommodate families with children who have sensory and behavioral needs. Communication is available in multiple languages. The entire process — from initial inquiry to post-treatment follow-up — is managed by a dedicated patient coordination team that understands the emotional weight of what families are considering.

Most importantly, the consultation is honest. We tell families what we believe we can support and what we cannot. That integrity is what builds the kind of trust that matters when a family is deciding whether to travel across the world for their child's care.

If you are considering autism stem cell therapy in Istanbul and want to understand whether it may be appropriate for your child, request a free consultation. There is no obligation, no pressure, and no cost.